Price movement over the last 24 hours
ARK Genomic Revolution ETF vs FuelCell Energy Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while FuelCell Energy Inc trades at $20.64 (market cap $1.68B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, FuelCell Energy Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | FCEL | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $36.01 |
52-Week Low | $23.09 | $3.92 |
Market Cap | — | $1.68B |
Enterprise Value | — | $1.53B |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FuelCell Energy (FCEL) trades at $21.03, down 8.57% amid recent volatility from a $225 million stock offering. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company continues to report losses with a net income margin of -132.41% in 2025, though revenue grew to $158.16 million. Recent news highlights a strategic partnership with Siemens to scale clean power solutions for data centers, a key growth area representing 90% of its sales pipeline.
FCEL presents a high-risk, high-reward opportunity driven by AI data center demand and new partnerships, but persistent profitability challenges and shareholder dilution from recent financing pose significant risks. Analyst consensus is mixed with a $20.13 price target, suggesting cautious optimism amid ongoing operational losses and competitive pressures in the fuel cell sector.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →